Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin resistance.

A Szczeklik1, J Musiał, A Undas

  • 1Department of Medicine, Jagiellonian University School of Medicine, Cracow, Poland. mmszczek@cyf-kr.edu.pl

Journal of Thrombosis and Haemostasis : JTH
|August 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidative stress associates with advanced glycation end products accumulation and aortic stenosis severity in patients with concomitant type 2 diabetes.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2025
Same author

Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

Effects of direct oral anticoagulants on thromboelastographic parameters and fibrin clot properties in patients with venous thromboembolism.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.

Lupus·2019
Same author

Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2019
Same author

Antithrombotic medications and their impact on fibrin clot structure and function.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2018
Same journal

The Natural Mutation Arg221aTrp in Human α-Thrombin Abrogates Physiological Na<sup>+</sup> Binding and Preferentially Hinders the Protease Anticoagulant Functions.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

A historical review of the biological, semantic and clinical aspects of aspirin resistance.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Association between Thrombus Neutrophil Extracellular Traps Content and Ischemic Stroke Recurrence.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Peptide-Mediated Inhibition of Surface-Initiated Thrombogenesis.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Physiological Anticoagulant Deficiencies: Pathogenesis, Diagnosis, and Clinical Implications.

Journal of thrombosis and haemostasis : JTH·2026
See all related articles

Some individuals do not respond to aspirin therapy, a phenomenon known as aspirin resistance. This impacts cardiovascular event prevention and requires further research for personalized antithrombotic treatment strategies.

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Treatment failures are observed with all medications, including aspirin.
  • Growing evidence suggests specific patient groups exhibit reduced responsiveness to aspirin's antithrombotic effects, termed aspirin resistance.
  • Aspirin resistance encompasses the inability of aspirin to prevent cardiovascular events or consistently alter laboratory markers of platelet activity.

Purpose of the Study:

  • To explore the concept and implications of aspirin resistance in clinical practice.
  • To review current understanding of aspirin resistance in various patient populations.
  • To discuss the potential role of pharmacogenetics in managing aspirin resistance.

Main Methods:

  • Review of existing evidence on aspirin resistance.

Related Experiment Videos

  • Analysis of clinical pharmacology and pharmacogenetics research findings.
  • Consideration of patient subgroups including myocardial infarction survivors, unstable angina patients, post-coronary artery bypass graft patients, and those with hypercholesterolemia.

    • Main Results:

    • Aspirin resistance is a recognized clinical issue in specific patient cohorts.
    • Laboratory tests for platelet activity are currently unreliable for predicting clinical outcomes or guiding therapeutic decisions in individual patients.
    • Pharmacogenetic approaches may offer future value in optimizing aspirin therapy.

    Conclusions:

    • Aspirin resistance must be considered in antithrombotic therapy for patients with recent myocardial infarction, unstable angina, coronary artery bypass grafts, and hypercholesterolemia.
    • Current laboratory tests are insufficient for reliable clinical decision-making regarding aspirin resistance.
    • Prospective clinical trials are needed to establish definitive conclusions and guide treatment strategies.